These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 798024)

  • 21. Adsorption and penetration of enveloped and naked vaccinia virus particles.
    Payne LG; Norrby E
    J Virol; 1978 Jul; 27(1):19-27. PubMed ID: 691111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sindbis virus infected L cells studied by ferritin-labelled antibodies.
    Wagner B; Veckenstedt A; Wagner M
    Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):431-9. PubMed ID: 1221673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.
    Bossart KN; Broder CC
    Methods Mol Biol; 2004; 269():309-32. PubMed ID: 15114023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adsorption of lymphocytes by cells infected by vaccinia virus].
    Saburi Y; Nagano Y
    C R Seances Soc Biol Fil; 1975; 169(4):1114-6. PubMed ID: 129247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic recombination between vaccinia virus strains distinct in hemagglutinin production and plaquing efficiency.
    Ando N; Matsumoto M
    Jpn J Microbiol; 1968 Dec; 12(4):495-504. PubMed ID: 5304283
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for a change in certain properties of vaccinia virus following trypsinization: improved virus quality and decreased adsorption.
    Graves IL
    Am J Vet Res; 1969 Mar; 30(3):461-9. PubMed ID: 5766740
    [No Abstract]   [Full Text] [Related]  

  • 27. Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara.
    Spehner D; Drillien R
    Virus Res; 2008 Oct; 137(1):129-36. PubMed ID: 18662728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to cowpox virus: polypeptide analysis of several major antigens.
    Kitamoto N; Tanimoto S; Hiroi K; Ozaki M; Miyamoto H; Wakamiya N; Ikuta K; Ueda S; Kato S
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():239-46. PubMed ID: 3806058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific removal of host-cell or vaccinia-virus antigens from extracts of infected cells by polyvalent disulphide-linked immunosorbents.
    Birkbeck TH; Stephen J
    J Gen Virol; 1970 Aug; 8(2):133-42. PubMed ID: 4097748
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccinia virus morphogenesis: a comparison of virus-induced antigens and polypeptides.
    Pennington TH
    J Gen Virol; 1973 Apr; 19(1):65-79. PubMed ID: 4205277
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles.
    Husain M; Moss B
    J Virol; 2005 Apr; 79(7):4080-9. PubMed ID: 15767409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors involved in the expression of cowpox virus-specific antigen in Sendai virus carrier cells.
    Tanaka J; Morita O; Hatano M
    J Gen Virol; 1976 Oct; 33(1):87-97. PubMed ID: 185330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of rabbit alveolar macrophages with a neurotropic vaccinia virus strain in vitro.
    Benda R; Danes L; Cinátl J
    Acta Virol; 1970 Sep; 14(5):353-61. PubMed ID: 4394660
    [No Abstract]   [Full Text] [Related]  

  • 34. The adsorption kinetics of vaccinia virus: demonstration of reversible adsorption (elution).
    Greenham LW; Collins MA; Smithson W
    Microbios; 1973; 7(26):103-15. PubMed ID: 4799060
    [No Abstract]   [Full Text] [Related]  

  • 35. Conditions for pox virus-specific microvilli formation studied during synchronized virus assembly.
    Krempien U; Schneider L; Hiller G; Weber K; Katz E; Jungwirth C
    Virology; 1981 Sep; 113(2):556-64. PubMed ID: 7269254
    [No Abstract]   [Full Text] [Related]  

  • 36. Single radial immunodiffusion test for detecting antibodies against surface antigens of intracellular and extracellular vaccinia virus.
    Prakash VJ; Norrby E; Payne L
    J Gen Virol; 1977 Jun; 35(3):465-72. PubMed ID: 407326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia virus as a tool for immunologic studies.
    Tatsis N; Sinnathamby G; Eisenlohr LC
    Methods Mol Biol; 2004; 269():267-88. PubMed ID: 15114021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.
    Senkevich TG; Moss B
    J Virol; 2005 Apr; 79(8):4744-54. PubMed ID: 15795260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    Payne LG
    J Gen Virol; 1980 Sep; 50(1):89-100. PubMed ID: 7441216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.
    Hruby DE; Lynn DL; Condit RC; Kates JR
    J Gen Virol; 1980 Apr; 47(2):485-8. PubMed ID: 6767809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.